University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Autologous CD34+ Hematopoietic Stem Cells Transduced ex Vivo With Elongation Factor 1 Alpha Shortened (EFS) Lentiviral Vector Encoding for the Human ADA Gene

Phase 1

Completed

Conditions: ADA-SCID

Interventions: Genetic: Infusion of autologous EFS-ADA LV CD34+ (OTL-101)
Drug: busulfan
Drug: PEG-ADA ERT

First Posted Date: 2013-05-13

Last Posted Date: 2022-08-03

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 46

Registration Number: NCT01852071

Locations: 🇺🇸
Mattel Children's Hospital, UCLA, Los Angeles, California, United States
🇺🇸
Mark O. Hatfield Clinical Research Center, NIH, Bethesda, Maryland, United States

Effects of Vitamin D Insufficiency in Man

Not Applicable

Completed

Conditions: Vitamin D Deficiency

Interventions: Dietary Supplement: Vitamin D3
Dietary Supplement: Vitamin D2

First Posted Date: 2013-05-07

Last Posted Date: 2020-03-03

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 300

Registration Number: NCT01848236

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

Perceptual Decision Making Under Conditions of Visual Uncertainty

Not Applicable

Conditions: Parkinson's Disease
Dystonia
Ataxia

Interventions: Procedure: Deep Brain Stimulation (DBS)

First Posted Date: 2013-05-03

Last Posted Date: 2015-12-18

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 120

Registration Number: NCT01845883

Locations: 🇺🇸
Neuroscience Research Building, Los Angeles, California, United States

UCLA-Amity Parolee Health Promotion Study

Not Applicable

Completed

Conditions: Hepatitis C
Drug Addiction
Hepatitis B
HIV

Interventions: Behavioral: Parolee Comprehensive Care + Phone Coach
Behavioral: Usual Care Group
Behavioral: Parolee Brief HBV Program + Phone Coach

First Posted Date: 2013-05-01

Last Posted Date: 2015-05-28

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 600

Registration Number: NCT01844414

Locations: 🇺🇸
Amistad de Los Angeles, Los Angeles, California, United States

Hyaluronic Acid Gels for Lower Lid Retraction

Phase 4

Withdrawn

Conditions: Ectropion

Interventions: Procedure: Hyaluronic acid
Procedure: Saline

First Posted Date: 2013-04-24

Last Posted Date: 2014-12-03

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT01838252

Locations: 🇺🇸
Jules Stein Eye Institute, Los Angeles, California, United States

Eban II: Intervention for HIV Sero-Discordant Couples

Not Applicable

Conditions: Sexually Transmitted Diseases
Disease Transmission, Infectious
HIV
Safe Sex

Interventions: Behavioral: Risk Reduction

First Posted Date: 2013-04-11

Last Posted Date: 2016-02-10

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 400

Registration Number: NCT01829282

Locations: 🇺🇸
Tarzana Treatment Centers, Long Beach, California, United States
🇺🇸
AIDS Project Los Angeles, Los Angeles, California, United States
🇺🇸
HIV Education & Prevention Project of Alameda County, Oakland, California, United States

and more 5 locations

An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents

Not Applicable

Completed

Conditions: Substance Abuse
Traumatic Stress

Interventions: Behavioral: Trauma-focused Substance Abuse Intervention

First Posted Date: 2013-04-08

Last Posted Date: 2023-09-29

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 117

Registration Number: NCT01825694

Locations: 🇺🇸
Behavioral Health Services, Los Angeles, California, United States

Whey Protein Effects on Gycemic Control and Vascular Function

Phase 1

Withdrawn

Conditions: Blood Sugar (Glucose) Control
Blood Vessel (Vascular) Dysfunction

Interventions: Dietary Supplement: Control protein
Dietary Supplement: Whey protein powder

First Posted Date: 2013-03-19

Last Posted Date: 2023-10-02

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT01814358

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

Field Administration of Stroke Therapy-Blood Pressure Lowering

Phase 2

Terminated

Conditions: Intracerebral Hemorrhage
Ischemic Stroke

Interventions: Drug: Glycerly Trinitrate

First Posted Date: 2013-03-14

Last Posted Date: 2020-10-29

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 4

Registration Number: NCT01811693

Locations: 🇺🇸
FAST-MAG Clinical Trial Coordinating Center, Los Angeles, California, United States
🇺🇸
Los Alamitos Medical Center, Los Alamitos, California, United States

Salivary Biomarkers for Sjögren's Syndrome Detection

Completed

Conditions: Sjögren's Syndrome

First Posted Date: 2013-03-08

Last Posted Date: 2019-04-19

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 420

Registration Number: NCT01807689

Locations: 🇺🇸
UCLA - School of Dentistry, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy